Symbols / ASRT
ASRT Chart
About
Assertio Holdings, Inc., a pharmaceutical company, provides various products to patients in the United States. Its pharmaceutical products include INDOCIN, an oral and suppository solution for the treatment of moderate to severe rheumatoid arthritis, including acute flares of chronic disease; ankylosing spondylitis and osteoarthritis; and acute painful shoulder and gouty arthritis. It also provides Sympazan, a benzodiazepine for the adjunctive treatment of seizures related with lennox-gastaut syndrome in patients aged two years of age or older; CAMBIA, a non steroidal anti inflammatory drug (NSAID) for the treatment of migraine pain, nausea, photophobia, and phonophobia; SPRIX, a NSAID for the short term management of moderate to moderately severe pain that requires analgesia at the opioid level; Otrexup, a single-dose auto-injector containing a prescription medicine and methotrexate that is used to treat patients with severe, active rheumatoid arthritis, and active polyarticular juvenile idiopathic arthritis, as well as treat adult with severe, recalcitrant, and disabling psoriasis; and ROLVEDON, a long-acting granulocyte colony-stimulating factor that is indicated to decrease the incidence of infection caused by febrile neutropenia. The company was formerly known as Assertio Therapeutics, Inc. and changed its name to Assertio Holdings, Inc. in May 2020. Assertio Holdings, Inc. was incorporated in 2020 and is headquartered in Lake Forest, Illinois.
Fundamentals
Scroll to Statements| Sector | Healthcare | Industry | Drug Manufacturers - Spe | Market Cap | 76.04M |
| Enterprise Value | 22.97M | Income | -28.92M | Sales | 137.35M |
| Book/sh | 16.49 | Cash/sh | 14.56 | Dividend Yield | — |
| Payout | 0.00% | Employees | 58 | IPO | — |
| P/E | — | Forward P/E | 7.90 | PEG | — |
| P/S | 0.55 | P/B | 0.72 | P/C | — |
| EV/EBITDA | 2.09 | EV/Sales | 0.17 | Quick Ratio | 1.41 |
| Current Ratio | 1.58 | Debt/Eq | 38.14 | LT Debt/Eq | — |
| EPS (ttm) | -4.50 | EPS next Y | 1.50 | EPS Growth | — |
| Revenue Growth | 69.40% | Earnings | 2026-03-09 | ROA | -4.17% |
| ROE | -24.48% | ROIC | — | Gross Margin | 65.47% |
| Oper. Margin | 28.72% | Profit Margin | -21.06% | Shs Outstand | 6.42M |
| Shs Float | 5.70M | Short Float | 4.22% | Short Ratio | 4.25 |
| Short Interest | — | 52W High | 15.15 | 52W Low | 7.65 |
| Beta | 0.73 | Avg Volume | 47.30K | Volume | 21.81K |
| Target Price | $37.44 | Recom | None | Prev Close | $11.94 |
| Price | $11.85 | Change | -0.75% |
Valuation Models
Price estimates from analyst targets and simple models.
1. Analyst consensus
$37.44
Mean price target
2. Current target
$11.85
Latest analyst target
3. DCF / Fair value
$58.39
Simplified: (Free Cash Flow ÷ Shares) × 18 (P/FCF multiple). Not a …
Ratings
Current target
$11.85
Low
$24.75
High
$45.00
Mean
$37.44
Latest analyst rating changes
| Date | Action | Analyst | Rating Change | Price Target |
|---|---|---|---|---|
| 2026-01-05 | main | HC Wainwright & Co. | Buy → Buy | $35 |
| 2025-08-12 | main | HC Wainwright & Co. | Buy → Buy | $3 |
| 2025-05-19 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2025-03-19 | main | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-12-16 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-11-25 | reit | HC Wainwright & Co. | Buy → Buy | $4 |
| 2024-07-26 | init | Maxim Group | — → Buy | $3 |
| 2024-07-03 | init | HC Wainwright & Co. | — → Buy | $4 |
| 2024-05-28 | init | Alliance Global Partners | — → Buy | $3 |
| 2024-03-12 | main | Lake Street | Buy → Buy | $3 |
| 2023-11-03 | main | BWS Financial | Buy → Buy | $4 |
| 2023-08-04 | reit | BWS Financial | Buy → Buy | $6 |
| 2023-05-10 | main | Lake Street | Buy → Buy | $9 |
| 2023-05-10 | main | BWS Financial | Buy → Buy | $10 |
| 2023-03-03 | main | BWS Financial | — → Buy | $8 |
| 2022-11-07 | init | Lake Street | — → Buy | $7 |
| 2022-05-18 | init | BWS Financial | — → Buy | $6 |
- Are Medical Stocks Lagging Assertio (ASRT) This Year? - Yahoo Finance Mon, 16 Feb 2026 08
- BEAM's Q4 Loss Narrower Than Expected, Revenues Rise Y/Y - Zacks Investment Research Wed, 25 Feb 2026 15
- Assertio Holdings, Inc.'s (NASDAQ:ASRT) Shares Bounce 35% But Its Business Still Trails The Industry - simplywall.st Sat, 07 Feb 2026 08
- Your 15 Assertio shares become 1 next week—here’s what happens - Stock Titan Mon, 22 Dec 2025 08
- Is Assertio (ASRT) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance Wed, 14 Jan 2026 08
- Can Assertio Stock Recover If Markets Fall? - Trefis Sun, 21 Dec 2025 08
- KOD Stock Up 24% in 3 Months: Here's What You Need to Know - Finviz Fri, 06 Feb 2026 08
- This company just cleared the bar to keep its Nasdaq listing after a split - Stock Titan Mon, 12 Jan 2026 08
- Assertio Holdings (NASDAQ:ASRT shareholders incur further losses as stock declines 11% this week, taking three-year losses to 72% - simplywall.st Wed, 05 Nov 2025 08
- New Strong Sell Stocks for September 16th - Zacks Investment Research ue, 16 Sep 2025 07
- Wall Street Analysts See a 230.56% Upside in Assertio (ASRT): Can the Stock Really Move This High? - Yahoo Finance Mon, 02 Feb 2026 08
- Assertio (Nasdaq: ASRT) sets Q3 results Nov. 10; expects guidance update within the current range - Stock Titan ue, 28 Oct 2025 07
- Assertio Holdings, Inc. (NASDAQ:ASRT) Just Released Its First-Quarter Results And Analysts Are Updating Their Estimates - simplywall.st hu, 15 May 2025 07
- Assertio (ASRT) Surpasses Q3 Earnings and Revenue Estimates - Yahoo Finance Mon, 10 Nov 2025 08
- Same-day cancer drug shot shows similar results to next-day dosing in trial - Stock Titan Fri, 09 Jan 2026 08
Insider Transactions
| Date | Shares | Value | Url | Text | Insider | Position | Transaction | Start Date | Ownership |
|---|---|---|---|---|---|---|---|---|---|
| 0 | 8959 | 6806.0 | — | Sale at price 0.76 per share. | STARK DAVID MATTHEW | Director | — | 2025-11-10 00:00:00 | D |
| 1 | 166665 | nan | — | — | O'GRADY BRENDAN P | Chief Executive Officer | — | 2025-05-30 00:00:00 | D |
| 2 | 38017 | nan | — | — | PATEL AJAY | Chief Financial Officer | — | 2025-05-12 00:00:00 | D |
| 3 | 38017 | nan | — | — | SCHWICHTENBERG PAUL | Officer | — | 2025-05-12 00:00:00 | D |
| 4 | 38017 | nan | — | — | SCHLESSINGER SAM | General Counsel | — | 2025-05-12 00:00:00 | D |
| 5 | 53750 | nan | — | — | EMANY SRAVAN KUMAR | Director | — | 2025-05-07 00:00:00 | D |
| 6 | 53750 | nan | — | — | KIRK SIGURD C | Director | — | 2025-05-07 00:00:00 | D |
| 7 | 53750 | nan | — | — | MCKEE WILLIAM T | Director | — | 2025-05-07 00:00:00 | D |
| 8 | 53750 | nan | — | — | MASON HEATHER L. | Director | — | 2025-05-07 00:00:00 | D |
| 9 | 53750 | nan | — | — | STARK DAVID MATTHEW | Director | — | 2025-05-07 00:00:00 | D |
Financials
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| TaxEffectOfUnusualItems | -1.20M | -54.51M | -3.92M | -1.35M |
| TaxRateForCalcs | 0.21 | 0.21 | 0.21 | 0.27 |
| NormalizedEBITDA | 12.59M | 36.68M | 90.97M | 43.73M |
| TotalUnusualItems | -5.69M | -259.58M | -18.69M | -5.00M |
| TotalUnusualItemsExcludingGoodwill | -5.69M | -259.58M | -18.69M | -5.00M |
| NetIncomeFromContinuingOperationNetMinorityInterest | -21.58M | -331.94M | 109.62M | -1.28M |
| ReconciledDepreciation | 25.83M | 28.23M | 33.40M | 29.08M |
| ReconciledCostOfRevenue | 39.04M | 26.32M | 17.96M | 14.87M |
| EBITDA | 6.90M | -222.90M | 72.29M | 38.73M |
| EBIT | -18.93M | -251.13M | 38.89M | 9.65M |
| NetInterestIncome | 182.00K | -10.89M | -7.96M | -10.22M |
| InterestExpense | 2.60M | 2.92M | 7.72M | 10.21M |
| InterestIncome | 3.22M | 2.40M | ||
| NormalizedIncome | -17.08M | -126.88M | 124.39M | 2.37M |
| NetIncomeFromContinuingAndDiscontinuedOperation | -21.58M | -331.94M | 109.62M | -1.28M |
| TotalExpenses | 143.74M | 136.03M | 98.14M | 96.59M |
| TotalOperatingIncomeAsReported | -24.48M | -243.54M | -39.41M | 9.42M |
| DilutedAverageShares | 6.35M | 4.74M | 3.64M | 2.88M |
| BasicAverageShares | 6.35M | 4.74M | 3.13M | 2.88M |
| DilutedEPS | -3.45 | -70.05 | 30.45 | -0.45 |
| BasicEPS | -3.45 | -70.05 | 34.95 | -0.45 |
| DilutedNIAvailtoComStockholders | -21.58M | -331.94M | 111.19M | -1.28M |
| AverageDilutionEarnings | 0.00 | 1.56M | ||
| NetIncomeCommonStockholders | -21.58M | -331.94M | 109.62M | -1.28M |
| NetIncome | -21.58M | -331.94M | 109.62M | -1.28M |
| NetIncomeIncludingNoncontrollingInterests | -21.58M | -331.94M | 109.62M | -1.28M |
| NetIncomeContinuousOperations | -21.58M | -331.94M | 109.62M | -1.28M |
| TaxProvision | 52.00K | 77.89M | -78.46M | 728.00K |
| PretaxIncome | -21.53M | -254.05M | 31.17M | -553.00K |
| OtherIncomeExpense | -2.93M | -259.20M | -18.96M | -4.76M |
| OtherNonOperatingIncomeExpenses | 2.77M | 377.00K | -278.00K | 243.00K |
| SpecialIncomeCharges | -5.69M | -259.58M | -18.69M | -5.00M |
| GainOnSaleOfBusiness | 0.00 | |||
| ImpairmentOfCapitalAssets | 5.22M | 279.64M | 0.00 | 0.00 |
| RestructuringAndMergernAcquisition | 476.00K | -20.06M | 18.69M | 5.00M |
| NetNonOperatingInterestIncomeExpense | 182.00K | -10.89M | -7.96M | -10.22M |
| TotalOtherFinanceCost | 439.00K | 10.37M | 236.00K | 15.00K |
| InterestExpenseNonOperating | 2.60M | 2.92M | 7.72M | 10.21M |
| InterestIncomeNonOperating | 3.22M | 2.40M | ||
| OperatingIncome | -18.78M | 16.04M | 58.09M | 14.43M |
| OperatingExpense | 104.52M | 109.01M | 79.39M | 80.75M |
| DepreciationAmortizationDepletionIncomeStatement | 25.64M | 27.53M | 32.61M | 28.11M |
| DepreciationAndAmortizationInIncomeStatement | 25.64M | 27.53M | 32.61M | 28.11M |
| Amortization | 25.64M | 27.53M | 32.61M | 28.11M |
| AmortizationOfIntangiblesIncomeStatement | 25.64M | 27.53M | 32.61M | 28.11M |
| ResearchAndDevelopment | 3.82M | 2.84M | 0.00 | 0.00 |
| SellingGeneralAndAdministration | 75.05M | 78.64M | 46.79M | 52.64M |
| GrossProfit | 85.73M | 125.05M | 137.49M | 95.18M |
| CostOfRevenue | 39.23M | 27.02M | 18.75M | 15.83M |
| TotalRevenue | 124.96M | 152.07M | 156.23M | 111.01M |
| OperatingRevenue | 122.86M | 151.88M | 157.52M | 112.00M |
| Line Item | 2023-12-31 | |||
|---|---|---|---|---|
| TreasurySharesNumber | 0.00 | |||
| OrdinarySharesNumber | 6.37M | 6.31M | 3.22M | 2.98M |
| ShareIssued | 6.37M | 6.31M | 3.22M | 2.98M |
| NetDebt | 1.93M | 36.68M | ||
| TotalDebt | 39.77M | 39.68M | 66.87M | 73.49M |
| TangibleBookValue | 40.61M | 26.67M | 27.73M | -113.64M |
| InvestedCapital | 159.73M | 176.21M | 292.60M | 175.91M |
| WorkingCapital | 87.86M | 77.62M | 36.95M | -31.52M |
| NetTangibleAssets | 40.61M | 26.67M | 27.73M | -113.64M |
| CapitalLeaseObligations | 1.12M | 1.47M | 0.00 | |
| CommonStockEquity | 121.08M | 138.00M | 225.72M | 102.41M |
| TotalCapitalization | 159.73M | 176.21M | 292.13M | 163.73M |
| TotalEquityGrossMinorityInterest | 121.08M | 138.00M | 225.72M | 102.41M |
| StockholdersEquity | 121.08M | 138.00M | 225.72M | 102.41M |
| RetainedEarnings | -673.12M | -651.54M | -319.60M | -429.23M |
| AdditionalPaidInCapital | 794.20M | 789.54M | 545.32M | 531.64M |
| CapitalStock | 9.00K | 9.00K | 5.00K | 4.00K |
| CommonStock | 9.00K | 9.00K | 5.00K | 4.00K |
| TotalLiabilitiesNetMinorityInterest | 163.65M | 148.42M | 188.19M | 224.13M |
| TotalNonCurrentLiabilitiesNetMinorityInterest | 48.96M | 54.97M | 92.87M | 89.11M |
| OtherNonCurrentLiabilities | 5.48M | 9.22M | 22.20M | 27.80M |
| DerivativeProductLiabilities | 168.00K | 308.00K | ||
| NonCurrentDeferredLiabilities | 3.55M | 5.76M | 4.27M | |
| NonCurrentDeferredTaxesLiabilities | 2.34M | 4.55M | 4.27M | |
| LongTermDebtAndCapitalLeaseObligation | 39.77M | 39.68M | 66.40M | 61.32M |
| LongTermCapitalLeaseObligation | 1.12M | 1.47M | 0.00 | |
| LongTermDebt | 38.65M | 38.21M | 66.40M | 61.32M |
| CurrentLiabilities | 114.69M | 93.44M | 95.32M | 135.02M |
| OtherCurrentLiabilities | 4.80M | 3.65M | 27.25M | 48.80M |
| CurrentDebtAndCapitalLeaseObligation | 470.00K | 12.17M | ||
| CurrentDebt | 470.00K | 12.17M | ||
| PensionandOtherPostRetirementBenefitPlansCurrent | 3.26M | 2.44M | 3.12M | 4.12M |
| PayablesAndAccruedExpenses | 106.63M | 87.35M | 64.48M | 69.92M |
| CurrentAccruedExpenses | 91.89M | 73.91M | 58.49M | 63.24M |
| InterestPayable | 867.00K | 867.00K | 1.59M | 1.69M |
| Payables | 14.74M | 13.44M | 5.99M | 6.68M |
| TotalTaxPayable | 0.00 | 0.00 | ||
| AccountsPayable | 14.74M | 13.44M | 5.99M | 6.68M |
| TotalAssets | 284.73M | 286.42M | 413.91M | 326.55M |
| TotalNonCurrentAssets | 82.18M | 115.36M | 281.65M | 223.05M |
| OtherNonCurrentAssets | 697.00K | 965.00K | 698.00K | |
| NonCurrentPrepaidAssets | 1.00K | 1.29M | 1.61M | 2.46M |
| NonCurrentDeferredAssets | 0.00 | 80.20M | 0.00 | |
| NonCurrentDeferredTaxesAssets | 0.00 | 80.20M | 0.00 | |
| InvestmentsAndAdvances | 268.00K | 1.58M | ||
| GoodwillAndOtherIntangibleAssets | 80.47M | 111.33M | 198.00M | 216.05M |
| OtherIntangibleAssets | 80.47M | 111.33M | 198.00M | 216.05M |
| NetPPE | 1.71M | 2.04M | 881.00K | 2.26M |
| AccumulatedDepreciation | -3.40M | -4.63M | -3.93M | -11.75M |
| GrossPPE | 5.11M | 6.67M | 4.81M | 14.01M |
| Leases | 2.55M | 2.94M | 2.94M | 10.52M |
| ConstructionInProgress | 0.00 | 528.00K | 0.00 | |
| OtherProperties | 1.15M | 1.29M | 157.00K | 755.00K |
| MachineryFurnitureEquipment | 1.41M | 1.91M | 1.71M | 2.73M |
| Properties | 0.00 | 0.00 | 0.00 | 0.00 |
| CurrentAssets | 202.55M | 171.06M | 132.26M | 103.50M |
| OtherCurrentAssets | 303.00K | 299.00K | 8.27M | 14.84M |
| PrepaidAssets | 9.76M | 11.97M | 8.27M | 14.84M |
| Inventory | 38.31M | 37.69M | 13.70M | 7.49M |
| FinishedGoods | 17.88M | 24.91M | 9.59M | 5.42M |
| WorkInProcess | 4.90M | 2.24M | 2.73M | 823.00K |
| RawMaterials | 15.52M | 10.54M | 1.37M | 1.24M |
| Receivables | 54.12M | 47.66M | 45.36M | 44.36M |
| AccountsReceivable | 54.12M | 47.66M | 45.36M | 44.36M |
| AllowanceForDoubtfulAccountsReceivable | -1.20M | -900.00K | -900.00K | |
| GrossAccountsReceivable | 55.32M | 48.56M | 46.26M | |
| CashCashEquivalentsAndShortTermInvestments | 100.05M | 73.44M | 64.94M | 36.81M |
| OtherShortTermInvestments | 49.47M | 0.00 | ||
| CashAndCashEquivalents | 50.59M | 73.44M | 64.94M | 36.81M |
| Line Item | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|
| FreeCashFlow | 26.41M | 48.98M | 78.32M | 5.47M |
| RepurchaseOfCapitalStock | -350.00K | -7.90M | -838.00K | -418.00K |
| RepaymentOfDebt | 0.00 | -10.50M | -70.75M | -9.84M |
| IssuanceOfDebt | 0.00 | 70.00M | 0.00 | |
| IssuanceOfCapitalStock | 0.00 | 7.02M | 44.86M | |
| CapitalExpenditure | -628.00K | -274.00K | -53.00K | |
| InterestPaidSupplementalData | 2.60M | 3.65M | 7.75M | 10.12M |
| IncomeTaxPaidSupplementalData | 1.59M | 4.03M | 0.00 | |
| EndCashPosition | 50.59M | 73.44M | 64.94M | 36.81M |
| BeginningCashPosition | 73.44M | 64.94M | 36.81M | 20.79M |
| ChangesInCash | -22.85M | 8.50M | 28.13M | 16.02M |
| FinancingCashFlow | -350.00K | -44.20M | -7.79M | 29.03M |
| CashFlowFromContinuingFinancingActivities | -350.00K | -44.20M | -7.79M | 29.03M |
| NetOtherFinancingCharges | -25.80M | -13.23M | -5.78M | |
| ProceedsFromStockOptionExercised | 34.00K | 193.00K | ||
| NetCommonStockIssuance | -350.00K | -7.90M | 6.18M | 44.44M |
| CommonStockPayments | -350.00K | -7.90M | -838.00K | -418.00K |
| CommonStockIssuance | 0.00 | 7.02M | 44.86M | |
| NetIssuancePaymentsOfDebt | 0.00 | -10.50M | -750.00K | -9.84M |
| NetLongTermDebtIssuance | 0.00 | -10.50M | -750.00K | -9.84M |
| LongTermDebtPayments | 0.00 | -10.50M | -70.75M | -9.84M |
| LongTermDebtIssuance | 0.00 | 70.00M | 0.00 | |
| InvestingCashFlow | -48.91M | 3.10M | -42.67M | -18.52M |
| CashFlowFromContinuingInvestingActivities | -48.91M | 3.10M | -42.67M | -18.52M |
| NetInvestmentPurchaseAndSale | -48.91M | 2.19M | 0.00 | 0.00 |
| SaleOfInvestment | 49.69M | 2.19M | 0.00 | 0.00 |
| PurchaseOfInvestment | -98.61M | 0.00 | ||
| NetBusinessPurchaseAndSale | 0.00 | 1.53M | -42.40M | -18.47M |
| SaleOfBusiness | 0.00 | 1.95M | 0.00 | 0.00 |
| PurchaseOfBusiness | 0.00 | -419.00K | -42.40M | -18.47M |
| NetPPEPurchaseAndSale | 0.00 | -628.00K | -274.00K | -53.00K |
| PurchaseOfPPE | 0.00 | -628.00K | -274.00K | -53.00K |
| OperatingCashFlow | 26.41M | 49.60M | 78.60M | 5.52M |
| CashFlowFromContinuingOperatingActivities | 26.41M | 49.60M | 78.60M | 5.52M |
| ChangeInWorkingCapital | 5.20M | 140.00K | -13.01M | -31.29M |
| ChangeInOtherWorkingCapital | 522.00K | |||
| ChangeInPayablesAndAccruedExpense | 16.91M | -42.39M | -13.44M | -39.15M |
| ChangeInAccruedExpense | 18.17M | -13.04M | -3.33M | -10.45M |
| ChangeInInterestPayable | 0.00 | -726.00K | -95.00K | |
| ChangeInPayable | -1.26M | -29.35M | -10.11M | -28.70M |
| ChangeInAccountPayable | -1.26M | -29.35M | -10.11M | -28.70M |
| ChangeInPrepaidAssets | 4.33M | -1.17M | 8.02M | 3.60M |
| ChangeInInventory | -9.58M | -4.97M | -6.59M | 4.27M |
| ChangeInReceivables | -6.46M | 48.67M | -996.00K | -11.00K |
| ChangesInAccountReceivables | -6.46M | 48.67M | -996.00K | -11.00K |
| OtherNonCashItems | -2.23M | -15.11M | 19.24M | 4.11M |
| StockBasedCompensation | 5.01M | 9.16M | 7.50M | 3.54M |
| ProvisionandWriteOffofAssets | 8.96M | 3.29M | 3.27M | 1.37M |
| AssetImpairmentCharge | 5.22M | 279.64M | 0.00 | 0.00 |
| DeferredTax | 0.00 | 76.20M | -80.38M | 0.00 |
| DeferredIncomeTax | 0.00 | 76.20M | -80.38M | 0.00 |
| DepreciationAmortizationDepletion | 25.83M | 28.23M | 33.40M | 29.08M |
| DepreciationAndAmortization | 25.83M | 28.23M | 33.40M | 29.08M |
| Depreciation | 25.83M | 28.23M | 33.40M | 29.08M |
| OperatingGainsLosses | -1.05M | |||
| GainLossOnSaleOfPPE | 0.00 | |||
| GainLossOnSaleOfBusiness | 0.00 | |||
| NetIncomeFromContinuingOperations | -21.58M | -331.94M | 109.62M | -1.28M |
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
Public Trades for ASRT
| Date | User | Asset | Broker | Type | Position Size | Entry Price | Patterns |
|---|